Učitavanje...
PURLs: How do these 3 diabetes agents compare in reducing mortality?
A meta-analysis reveals that there may be advantages associated with SGLT-2 inhibitors and GLP-1 agonists that are not associated with DPP-4 inhibitors.
Spremljeno u:
| Izdano u: | J Fam Pract |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontline Medical Communications Inc
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6484967/ https://ncbi.nlm.nih.gov/pubmed/30870538 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|